Takahiro Sumimoto

Yufu, 8795593, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Candidate-gene-based study of CYP3A-related single-nucleotide polymorphisms using 4β-hydroxycholesterol/cholesterol ratio as biomarker in a Japanese cohort.

Candidate-gene-based study of CYP3A-related single-nucleotide polymorphisms using 4β-hydroxycholesterol/cholesterol ratio as biomarker in a Japanese cohort.

Journal: European journal of clinical pharmacology

Published: February 08, 2026

Association between anamorelin therapy and renal function in patients with cancer cachexia: a propensity score-matched retrospective study.

Association between anamorelin therapy and renal function in patients with cancer cachexia: a propensity score-matched retrospective study.

Journal: European journal of clinical pharmacology

Published: January 21, 2026

Discovery of novel plasma biomarkers for OATP1B1 activity using nontargeted metabolomics.

Discovery of novel plasma biomarkers for OATP1B1 activity using nontargeted metabolomics.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: November 11, 2025

Development and validation of simultaneous quantification of total and free clozapine and its two metabolites in human plasma using ultra high-performance liquid chromatography coupled to tandem mass spectrometry.

Development and validation of simultaneous quantification of total and free clozapine and its two metabolites in human plasma using ultra high-performance liquid chromatography coupled to tandem mass spectrometry.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Published: June 17, 2025

Wide-range and high-throughput quantification of anamorelin in human plasma using ultra-high-performance liquid chromatography coupled to tandem mass spectrometry.

Wide-range and high-throughput quantification of anamorelin in human plasma using ultra-high-performance liquid chromatography coupled to tandem mass spectrometry.

Journal: Clinical biochemistry

Published: January 20, 2025

Impact of Cancer Cachexia Progression on OATP1B1 Transport Activity: Quantitative Analysis Using Coproporphyrin-I as an Endogenous Biomarker.

Impact of Cancer Cachexia Progression on OATP1B1 Transport Activity: Quantitative Analysis Using Coproporphyrin-I as an Endogenous Biomarker.

Journal: Clinical pharmacology and therapeutics

Published: December 18, 2024

Comparison of Efficacy, Safety, and Economic Outcomes Between Biosimilar ABP 215 and Originator Bevacizumab in Japanese Patients With Colorectal Cancer.

Comparison of Efficacy, Safety, and Economic Outcomes Between Biosimilar ABP 215 and Originator Bevacizumab in Japanese Patients With Colorectal Cancer.

Journal: Cureus

Published: October 24, 2024

Comparison of Preparation Efficiency and Therapeutic Safety between Brand-Name and Generic Products of Pemetrexed

Comparison of Preparation Efficiency and Therapeutic Safety between Brand-Name and Generic Products of Pemetrexed

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: July 15, 2024

Clinical relevance of immune checkpoint inhibitors for the analgesic effect of opioids: A retrospective propensity score analysis.

Clinical relevance of immune checkpoint inhibitors for the analgesic effect of opioids: A retrospective propensity score analysis.

Journal: British journal of clinical pharmacology

Published: June 05, 2024

Cathepsin G-induced malignant progression of MCF-7 cells involves suppression of PAF signaling through induced expression of PAFAH1B2.

Cathepsin G-induced malignant progression of MCF-7 cells involves suppression of PAF signaling through induced expression of PAFAH1B2.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: November 14, 2021

Comparison of Treatment Safety Between Brand-Name Product and Biosimilar of Trastuzumab

Comparison of Treatment Safety Between Brand-Name Product and Biosimilar of Trastuzumab

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: July 16, 2021

Exacerbation of cancer pain after administering immune checkpoint inhibitor in a patient taking opioids: A case report.

Exacerbation of cancer pain after administering immune checkpoint inhibitor in a patient taking opioids: A case report.

Journal: Journal of clinical pharmacy and therapeutics

Published: June 09, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026